AI-enhanced drug design software enters early access program

DeepMirror, a University of Cambridge spin-out, introduces its Early Access Programme for intuitive design software dedicated to discovering innovative therapeutic drugs. Click to read more...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Boston ,Massachusetts ,United States ,Andrew Mcteague ,Max Jakobs ,Boston Consulting Group ,University Of Cambridge ,Early Access Programme ,Wellcome ,Lead Optimisation ,Wellcome Trust ,Boston Consulting ,Senior Scientist ,Medicinal Chemistry ,Morphic Therapeutic ,Drug ,Discovery ,Eepmirror ,Design ,User ,Software ,Herapeutic ,Friendly ,Head ,Programme ,